320 related articles for article (PubMed ID: 10556041)
1. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
2. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
Chill JH; Quadt SR; Anglister J
Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
5. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
6. Differential receptor subunit affinities of type I interferons govern differential signal activation.
Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
[TBL] [Abstract][Full Text] [Related]
7. Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity.
Slutzki M; Jaitin DA; Yehezkel TB; Schreiber G
J Mol Biol; 2006 Jul; 360(5):1019-30. PubMed ID: 16815442
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.
Roisman LC; Jaitin DA; Baker DP; Schreiber G
J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819
[TBL] [Abstract][Full Text] [Related]
9. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface.
Piehler J; Roisman LC; Schreiber G
J Biol Chem; 2000 Dec; 275(51):40425-33. PubMed ID: 10984492
[TBL] [Abstract][Full Text] [Related]
10. Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNalpha2.
Piehler J; Schreiber G
J Mol Biol; 1999 May; 289(1):57-67. PubMed ID: 10339405
[TBL] [Abstract][Full Text] [Related]
11. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
12. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
[TBL] [Abstract][Full Text] [Related]
14. Fast transient cytokine-receptor interactions monitored in real time by reflectometric interference spectroscopy.
Piehler J; Schreiber G
Anal Biochem; 2001 Feb; 289(2):173-86. PubMed ID: 11161311
[TBL] [Abstract][Full Text] [Related]
15. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
16. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
[TBL] [Abstract][Full Text] [Related]
17. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
18. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
19. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity.
Runkel L; deDios C; Karpusas M; Betzenhauser M; Muldowney C; Zafari M; Benjamin CD; Miller S; Hochman PS; Whitty A
Biochemistry; 2000 Mar; 39(10):2538-51. PubMed ID: 10704203
[TBL] [Abstract][Full Text] [Related]
20. Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2.
Dhalluin C; Ross A; Huber W; Gerber P; Brugger D; Gsell B; Senn H
Bioconjug Chem; 2005; 16(3):518-27. PubMed ID: 15898717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]